BRIEF published on 04/10/2025 at 15:05, 1 year 6 months ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
BRIEF published on 04/10/2025 at 15:05, 1 year 6 months ago Eckert & Ziegler : Le consul américain visite l'usine radiopharmaceutique de Braunschweig Traitement Du Cancer Produits Radiopharmaceutiques Lutécium-177 Visite Du Consul Américain Investissement D'expansion
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year 6 months ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 1 year 7 months ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
BRIEF published on 03/27/2025 at 07:50, 1 year 7 months ago Eckert & Ziegler annonce une année record en 2024 Eckert & Ziegler Résultats Financiers 2024 Secteur Médical Produits Isotopiques Prévisions Pour 2025
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 7 months ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 7 months ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
BRIEF published on 03/25/2025 at 09:35, 1 year 7 months ago Eckert & Ziegler fournira de l'actinium-225 à Actinium Pharmaceuticals Essais Cliniques Leucémie Myéloïde Aiguë Approvisionnement En Actinium 225 Radiothérapie Ciblée Pénurie Mondiale
PRESS RELEASE published on 03/25/2025 at 09:30, 1 year 7 months ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 1 year 7 months ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
Published on 11/06/2026 at 22:15, 3 hours 54 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 13 hours 9 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 13 hours 39 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 13 hours 39 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 5 hours 54 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 5 hours 54 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 6 hours 54 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 7 hours 9 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 7 hours 37 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 7 hours 2 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 7 hours 5 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 7 hours 7 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 7 hours 9 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
